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Abstract
The children of older fathers have increased risks of developing schizophrenia spectrum disorders, and among those who
develop these disorders, those with older fathers present with more severe clinical symptoms. However, the influence of
advanced paternal age on other important domains related to schizophrenia, such as quantitative endophenotype deficit
levels, remains unknown. This study investigated the associations between paternal age and level of endophenotypic
impairment in a well-characterized family-based sample from the Consortium on the Genetics of Schizophrenia (COGS). All
families included at least one affected subject and one unaffected sibling. Subjects met criteria for schizophrenia (probands;
n=293) or were unaffected first-degree siblings of those probands (n=382). Paternal age at the time of subjects’ birth was
documented. Subjects completed a comprehensive clinical assessment and a battery of tests that measured 16
endophenotypes. After controlling for covariates, potential paternal age–endophenotype associations were analyzed using
one model that included probands alone and a second model that included both probands and unaffected siblings.
Endophenotype deficits in the Identical Pairs version of the 4-digit Continuous Performance Test and in the Penn
Computerized Neurocognitive Battery verbal memory test showed significant associations with paternal age. However, after
correcting for multiple comparisons, no endophenotype was significantly associated with paternal age. These findings
suggest that factors other than advanced paternal age at birth may account for endophenotypic deficit levels in
schizophrenia.
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Introduction
Paternal age and risk of schizophrenia
The children of older fathers have an increased risk of
developing a number of psychiatric disorders that include deficits
in behavioral and cognitive functioning. Studies have demonstrat-
ed associations between advanced paternal age and epilepsy [1],
bipolar disorder [2,3], autism [4,5,6,7], dyslexia [8], neurocogni-
tive impairments [9], and deficits in social functioning [10]. The
literature also suggests a relationship between patients’ advanced
paternal age at birth and the development of schizophrenia
spectrum disorders. Malaspina and colleagues [11] found that
after paternal age at birth exceeded 25, the relative risk of
schizophrenia for offspring increased with each five-year incre-
ment in paternal age at birth and that the greatest risk occurred for
the offspring of the oldest paternal group: fathers age 45 and older.
In that study, older paternal age at birth remained a significant
predictor of schizophrenia risk even after controlling for maternal
PLOS ONE | www.plosone.org 1 February 2014 | Volume 9 | Issue 2 | e88379age. Dalman and Allebeck [12] showed that having a father age 45
or older at birth was associated with a doubled risk of developing
schizophrenia compared to having a father age 20 to 24. Similarly,
Byrne and colleagues [13] demonstrated a sex-specific relationship
between advanced paternal age and schizophrenia, showing that
the risk for schizophrenia increased for sons of fathers age 55 years
and older and for daughters of fathers age 50 years and older.
However, a recent meta-analysis did not find gender differences
[4,14,15,16,17,18,19].
Paternal age, severity of symptoms, and cognitive
functioning in schizophrenia
Among those offspring who develop schizophrenia, advanced
paternal age has also been associated with severity of clinical
symptoms. Rosenfield and colleagues [20] found that patients with
no family history of schizophrenia and a paternal age at birth of $
35 showed more severe symptoms (higher total scores and higher
positive, activation, and autistic preoccupation scores on the
Positive and Negative Syndrome Scale [PANSS]) during a
medication-free phase than patients with younger fathers.
Others have suggested that paternal age is also associated with
cognitive functioning in schizophrenia. Using demographic and
clinical data collected from subjects with schizophrenia or
schizoaffective disorder, Lee and colleagues [21] defined paternal
age–related schizophrenia (PARS) as having a father age 35 or
older at the time of the subject’s birth and not having a family
history of schizophrenia. They performed numerous k-means
cluster analyses and found that 20 of 34 (59%) individuals with
PARS clustered in a group which exhibited significantly greater
discrepancy between verbal and performance intelligence on the
WAIS-R subtests compared to subjects in six other clusters. These
findings suggest that the cognitive performance deficits in patients
with schizophrenia may be associated with advanced paternal age.
Goals of the current study
Despite the evidence demonstrating paternal age effects on the
development of schizophrenia-spectrum disorders in offspring, we
do not know whether advanced paternal age is associated with the
endophenotypic deficits observed in schizophrenia. By studying
these associations, we have the opportunity to understand whether
paternal age has differential effects on schizophrenia-related
neurophysiological and neurocognitive endophenotypic deficits
with known neurobiological functions. Endophenotypes, which
were first described by Gottesman and Gould [22], are defined as
stable traits that are more common in affected individuals but are
not associated with the severity of the illness, that cosegregate with
illness in families, and that are more common among family
members of affected individuals.
Studying the impact of paternal age at birth on both individuals
with schizophrenia and their unaffected siblings may highlight
important relationships between nonfamilial factors and endophe-
notypes for schizophrenia. Thus, in the current study, we
hypothesized that advanced paternal age would be associated
with greater deficits in neurophysiological and neurocognitive
schizophrenia-related endophenotypes.
Materials and Methods
Clinical ascertainment and assessment
The current study utilizes data from the Consortium on the
Genetics of Schizophrenia (COGS) [23,24,25], a multisite, family-
based study on the genetics and heritability of neurocognitive and
neurophysiologic schizophrenia endophenotypes. Participants in
this study met COGS criteria as schizophrenia probands (n=293)
or unaffected siblings of those probands (n=382). The probands
and their unaffected siblings completed a structured clinical
diagnostic interview (the Diagnostic Interview for Genetic Studies
[26]) and a best-estimate consensus diagnostic procedure that
included a comprehensive evaluation of psychotic, mood, and
substance use disorders and related symptomology [23,27]. This
information was used in concert with a standard medical record
review to establish handedness, age at onset of psychosis (for
probands), education level, parental education level, and parental
age; the Family Interview for Genetics Studies (FIGS) [28] was
used to assess subjects’ family history of schizophrenia or
schizoaffective disorder; and the reading subtest of the Wide
Range Achievement Test, 3rd edition (WRAT-3) [29], was used to
estimate premorbid intellectual functioning. The probands were
also assessed using the Schedule for the Assessment of Negative
Symptoms (SANS) [30] and Schedule for the Assessment of
Positive Symptoms (SAPS) [31]; all probands met Diagnostic and
Statistics Manual of Mental Disorders, 4th edition (DSM-IV),
diagnostic criteria for schizophrenia. Recruitment and ascertain-
ment strategies, in-depth inclusion and exclusion criteria, and in-
person training and quality assurance guidelines for the assessment
team and endophenotype testers are detailed in an earlier
manuscript by Calkins and colleagues [23]. The COGS encom-
passes study sites at the University of California, San Diego;
University of California, Los Angeles; University of Colorado,
Denver; Harvard University; Mount Sinai School of Medicine;
University of Pennsylvania; and University of Washington;
institutional review boards at these sites and/or their affiliated
institutions approved the COGS procedures in adults age 18 and
older. All subjects demonstrated an understanding of their
involvement in the study and provided signed informed consent
before commencing study procedures as well as ongoing verbal
and physical assent throughout the study.
Endophenotype assessment battery
The COGS endophenotype assessment battery and its use in
the different COGS studies have been discussed in detail
elsewhere. For the current study, endophenotypes included
standard assessments of antisaccade performance (proportion
correct) [32]; prepulse inhibition (PPI) [33], which was measured
as 1006[1 2 (magnitude of startle to pulse preceded by prepulse/
magnitude of startle to pulse without a preceding prepulse)] using
60 msec pulses; the Degraded Stimulus (DS), 3-digit Identical Pairs
(IP), and 4-digit IP versions of the Continuous Performance Test
(CPT), which were measured using the signal/noise discrimination
index (d9) [34]; the Forward and Reordered condition of the
Letter-Number Span (LNS) [35], measured as the total number of
correctly recalled sequences; the California Verbal Learning Test
(CVLT), specifically the total and total semantic clustering scores
on trials 1–5 (CVLT total and CVLT semantic) [36]; and the
abstraction and mental flexibility, verbal memory, face memory,
spatial memory, spatial processing, sensorimotor dexterity, and
emotion processing cognitive domains of the Penn Computerized
Neurocognitive Battery (CNB) [34,37], which were measured
using the number of correct responses standardized to a z-score
based on the COGS community control subjects.
Data analysis
Demographic differences between schizophrenia probands and
their unaffected siblings were tested using linear mixed-effects
models [38] for continuous variables and generalized linear mixed-
effects models [39] for categorical variables. In these analyses,
family membership served as a random effect to account for the
relatedness of observations among family members. Families in
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diagnosis of schizophrenia or schizoaffective disorder were
considered multiplex; all other families were considered simplex.
Paternal age at birth was calculated by subtracting offspring age
from parental age; it was treated as continuous.
To assess a possible effect of paternal age on the severity of
symptoms, or on the age of onset of symptoms, separate linear
models were used to model SANS, SAPS, and age of onset as a
function of paternal age, gender, and a paternal age–by-gender
interaction.
We conducted two separate types of analyses to test the
association of each endophenotype with paternal age: proband-
only analyses and simultaneous analyses of both the probands and
their unaffected siblings. Our proband-only analyses consisted of
linear regression models in which an endophenotype was modeled
as a function of paternal age along with the covariates test site,
subject age, subject gender, multiplex status, and parental
education (maximum grade level of mother or father), as well as
paternal age–by-gender and paternal age–by–multiplex status
interaction terms. Simultaneous analyses of probands and their
unaffected siblings consisted of linear mixed-effects models that
mirrored those used in the proband-only analyses but with family
as a random effect, with group (proband versus sibling) as a fixed
effect, and with additional interaction terms: all second-order
interaction terms involving group. For all analyses of the CVLT
endophenotype, WRAT-3 standardized reading scores were
included as a covariate in place of parental education as suggested
by Stone and colleagues [36]. Missing values for parental
education and WRAT-3 scores were imputed as described
previously [36,40].
For any term involving paternal age at subject birth, nominal
significance was defined as a P value less than 5%. Adjustment for
multiple comparisons was performed using the method of Holm
[41]. One set of adjustments accounted for the 16 endopheno-
types, and another set of adjustments accounted for the 16
endophenotypes and two models (probands only versus probands
plus unaffected siblings). Neither set of adjustments accounted for
the presence of multiple terms that involved paternal age at birth.
We performed three sets of sensitivity analyses: one in which
interaction terms were omitted, one in which paternal age was
treated as categorical (,40 years old versus $40), and one in
which interactions terms were omitted and paternal age was
treated as categorical.
All analyses were performed using R version 2.12.2 [42]. Linear
mixed-effects models were fit using the R package nlme [43], and
generalized linear mixed-effects models were fit using the R
package lme4 [44].
Results
Demographic and clinical variables
For subjects with at least one valid endophenotype, paternal age
at birth was obtained from 293 of 345 (85%) schizophrenia
probands and from 382 of 456 (84%) unaffected siblings. The 382
unaffected siblings represent 279 families, of which 17 (6%) were
multiplex; 18 of the 293 probands (6%) were from multiplex
families. As expected, probands and siblings were similar in age
and paternal age at birth, but probands had a significantly higher
proportion of males and smokers, had significantly lower average
education levels, and performed worse on the WRAT-3 (Table 1).
Of the 293 probands, 23 (8%) were born to fathers 40 years old or
older.
Association of paternal age with symptom levels and age
of onset in probands
Seven (2%) of the probands were missing values for SANS and
SAPS, and 5 (2%) were missing values for age at onset; these
probands were all born to fathers less than 40 years old. None of
the linear models for SANS, SAPS, or age of onset in probands
showed a significant effect for paternal age or a paternal age–by-
gender interaction.
Association of paternal age with endophenotypic deficits
Table 2 presents descriptive statistics for the endophenotypes by
subject group. Table 3 displays the results of linear models that test
the association of paternal age at birth with endophenotypic
deficits in probands alone and the results of linear mixed-effects
models that test the association of paternal age at birth with
endophenotypic deficits in probands and unaffected siblings
combined.
Of the 16 endophenotypes considered, only the 4-digit CPT-IP
(CPT-IP 4-digit) and CNB verbal memory test showed nominally
significant associations with paternal age. CPT-IP 4-digit showed a
positive association with paternal age (i.e., subjects with older
fathers performed better), and the CNB verbal memory test
showed an interaction effect between paternal age and multiplex
status (test scores were more negatively associated with paternal
age for multiplex subjects than simplex subjects). In the analysis of
both probands and unaffected siblings, the verbal memory test also
showed an interaction effect between paternal age and gender (test
scores were more negatively associated with paternal age for
females than males). After adjusting for multiple comparisons
accounting for the 16 endophenotypes, none of the results
remained statistically significant (Table 3 shows only results
involving paternal age that are nominally significant before
adjusting for multiple comparisons; Table S1 shows results for
all terms involving paternal age for all endophenotypes, regardless
of significance).
For the sensitivity analyses, when paternal age at birth was
treated as continuous and interaction terms were omitted from the
models, only the CPT-IP 4-digit and the California Verbal
Learning Test semantic clustering (CVLT semantic) showed
significant associations with paternal age. CPT-IP 4-digit again
showed a positive association with paternal age and CVLT
semantic showed a negative association. After adjusting for
multiple comparisons accounting for the 16 endophenotypes, only
the effect of paternal age on CPT-IP 4-digit in the probands-only
analysis remained statistically significant. After adjusting for
multiple comparisons accounting for the 16 endophenotypes and
two models (probands-only versus probands plus unaffected
siblings), none of the results remained statistically significant.
When paternal age at birth was treated as categorical (,40
versus $40) and interaction terms were omitted from the models,
CPT-IP 4-digit again showed a positive association with paternal
age, but this association was not significant after adjusting for
multiple comparisons accounting for the 16 endophenotypes.
When paternal age at birth was treated as categorical (,40 versus
$40) and interaction terms were included in the models, CPT-IP
3-digit, CPT-IP 4-digit, and CNB spatial ability all showed positive
associations with paternal age. Also, similar to when paternal age
was treated as continuous, in the analysis of both probands and
unaffected siblings, CNB verbal memory showed an interaction
effect between paternal age and multiplex status (test scores were
more negatively associated with paternal age for multiplex subjects
than simplex subjects). CNB sensorimotor dexterity showed the
same kind of paternal age–by–multiplex status interaction effect,
and CNB abstraction/mental flexibility showed an interaction
Paternal Age and Schizophrenia Endophenotypes
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associated with paternal age for probands and negatively
associated with paternal age for unaffected siblings). After
adjusting for multiple comparisons accounting for the 16
endophenotypes, only two effects remained statistically significant:
the effect of paternal age on spatial ability, for probands only, and
the paternal age–by–multiplex status interaction, for probands and
their unaffected siblings. After adjusting for multiple comparisons
accounting for the 16 endophenotypes and two models, none of
the results remained statistically significant.
Discussion
Our overall findings do not suggest that advanced paternal age
at birth negatively affects endophenotypes associated with
schizophrenia; rather, our findings imply that factors other than
paternal age at birth are operating to influence performance on
these neurocognitive and neurophysiologic measures.
The current study operated under the initial hypothesis that
advanced paternal age may serve as a proxy for the presence of
genetic variations that may increase the risk of developing
schizophrenia and may also potentially increase schizophrenia-
associated endophenotypic deficit levels. Some investigators have
hypothesized that the association between the risk for sporadic
schizophrenia and advanced paternal age can be attributed to de
novo mutations in paternal germ lines [11]. Specifically, given the
increased rate of mitotic cell division in the sperm cells relative to
the oocyte, the possibility of error in gene replication greatly
increases along with advanced paternal age. Indeed, advanced
paternal age has been linked with human and rodent sex
chromosomal aneuploidies as well as a fourfold increase in
structural chromosomal abnormalities (i.e., breaks and/or rear-
rangements) and other DNA damage in human and mouse sperm
[45]. Thus, molecular mechanisms associated with aging males
could explain the relationship between advanced paternal age and
the development of major psychiatric disorders such as schizo-
phrenia.
However, in the current study, paternal age at birth played little
to no role in influencing performance on endophenotypic
measures. For example, although we found an association between
paternal age at birth and performance on the CPT-IP 4-digit, this
association ran counter to our hypothesis in that our subjects with
older fathers actually performed better on this measure. In the
analyses that combined the probands and unaffected siblings, we
found a significant paternal age–by–multiplex status interaction
with the verbal memory component of the CNB such that test
scores in multiplex subjects showed a more negative association
with paternal age than in simplex subjects. However, after
adjustment for multiple comparisons, none of these associations
remained statistically significant, suggesting that these findings
may be due primarily to Type I error.
Table 1. Demographic and clinical characteristics of schizophrenia subjects and unaffected siblings.
Schizophrenia subjects (N=293) Unaffected siblings (N=382
a)
n% n% P value
b Odds Ratio (95% CI)
c
Gender (male) 222 76 173 45 ,0.0001 3.9 (2.8, 5.5)
Race (white) 216 74 305 80
Smoker
d 126 44 62 16 ,0.0001 4.0 (2.7, 5.7)
Multiplex status
e 18 6 28 7
Mean SD (Min, Max) Mean SD (Min, Max) P value
b Difference (95% CI)
c
Age (years) 33.7 10.5 (18, 62) 35.0 11.1 (18, 66) 0.21
Education (years)
f 13.6 2.1 (8, 20) 15.4 2.4 (7, 25) ,0.0001 21.7 (22.0, 21.4)
Parental education (years)
g 15.9 3.4 (0, 25) 15.8 3.6 (0, 25)
WRAT-3
h 102.5 10.9 (69, 122) 106.5 9.5 (64, 125) ,0.0001 24.0 (25.3, 22.7)
Age at onset of symptoms (years)
i 20.9 5.5 (6, 51)
SANS
j 9.5 6.0 (0, 25)
SAPS
k 6.2 4.1 (0, 20)
Paternal age at birth (years) 30.7 6.3 (18, 63) 30.7 6.3 (16, 66) 0.36
Abbreviations: CI, confidence interval; SANS, Schedule for the Assessment of Negative Symptoms; SAPS, Schedule for the Assessment of Positive Symptoms; SD,
standard deviation; WRAT-3, Wide Range Achievement Test, 3rd edition.
aUnaffected siblings represent 279 families, of which 17 (6%) were multiplex.
bBetween-group P values are based on generalized linear mixed-effects models for categorical variables and linear mixed-effects models for continuous variables; P
values were not computed for race, multiplex status, parental education, or age at onset of symptoms.
cFor continuous variables, differences between groups (probands – unaffected siblings) and 95% CIs for differences are based on linear mixed-effects models; for
categorical variables, odds ratios and 95% CIs for odds ratios are based on generalized linear mixed-effects models. CIs are shown only for variables where the P value
for the between-group test is ,0.05.
d4 missing values for schizophrenia subjects; 2 missing values for unaffected siblings.
eMultiplex families were those for which at least one parent or sibling of the proband had a history of schizophrenia or schizoaffective disorder.
f2 missing values for schizophrenia subjects; 2 missing values for unaffected siblings.
g6 missing values for schizophrenia subjects; 3 missing values for unaffected siblings.
h10 missing values for schizophrenia subjects; 12 missing values for unaffected siblings.
i5 missing values for schizophrenia subjects.
j7 missing values for schizophrenia subjects; 73 missing values for unaffected siblings.
k7 missing values for schizophrenia subjects; 74 missing values for unaffected siblings.
doi:10.1371/journal.pone.0088379.t001
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Schizophrenia subjects (N=293) Unaffected siblings (N=382)
Endophenotype n Mean SD (Min, Max) n Mean SD (Min, Max)
Antisaccade (proportion correct)
a 242 0.62 0.26 (0, 0.98) 331 0.81 0.20 (0.02, 1)
PPI (percent)
b 198 44 28 (2107, 90) 275 46 26 (264, 94)
DS-CPT (d9)
c 252 2.4 1.1 (0.1, 5.4) 349 2.7 1.0 (0.0, 5.3)
CPT-IP 3-digit (d9)
d 242 2.2 0.8 (20.2, 4.3) 348 3.0 0.8 (0.0, 4.8)
CPT-IP 4-digit (d9)
e 241 1.3 0.7 (20.2, 3.5) 348 2.0 0.8 (20.3, 4.8)
LNS Forward (number correct)
f 282 13 3 (4, 21) 370 14 3 (4, 21)
LNS Reordered (number correct)
g 281 9 3 (1, 18) 368 11 3 (4, 20)
CVLT total (number correct)
h 277 43 13 (11, 75) 369 55 9 (28, 76)
CVLT semantic (number correct)
i 277 0.5 1.5 (22.2, 7.6) 369 1.9 2.2 (22.4, 8.4)
CNB (z-transformed number correct)
j
Abstraction/mental flexibility 258 20.56 1.2 (22.5, 1.3) 347 0.06 0.88 (22.5, 1.3)
Verbal memory 149 20.71 1.2 (24.0, 1.5) 177 20.03 0.93 (24, 1.5
Face memory 267 20.83 1.2 (24.0, 1.6) 350 0.09 0.86 (23.2, 1.7)
Spatial memory 261 20.61 1.1 (23.4, 1.8) 349 0.09 0.87 (22.4, 1.8)
Spatial processing 247 20.06 1.1 (23.7, 1.4) 332 0.16 0.92 (24, 1.4)
Sensorimotor dexterity 263 20.20 1.0 (24.0, 0.1) 345 0.07 0.37 (24, 0.12)
Emotion processing 261 20.88 1.4 (24.0, 1.9) 348 0.13 0.86 (23.9, 1.9)
Abbreviations: CNB, Computerized Neurocognitive Battery; CPT-IP, Continuous Performance Test, Identical Pairs version; CVLT, California Verbal Learning Test; DS-CPT,
Degraded Stimulus Continuous Performance Test; LNS, Letter-Number Span; PPI, prepulse inhibition.
aProportion correct out of a maximum of 60 trials.
bPrepulse inhibition using 60 msec pulses.
100 6[1 2 (magnitude of startle to pulse preceded by prepulse/magnitude of startle to pulse without a preceding prepulse)].
cOverall signal/noise discrimination (d9).
dThree-digit d9.
eFour-digit d9.
fAfter each sequence, the participant is asked to recall the numbers and letters in the same exact order, with no reordering of the stimuli. The number of digits and
letters increases by one on each trial, from one up to a maximum length of 8 stimuli. Three sequences of the same length are presented during each trial. The test is
discontinued when the subject fails three consecutive sequences of the same length. The score is the total number of correctly recalled sequences.
gAfter each sequence, the participant is asked to repeat the numbers in ascending order first and then the letters in alphabetical order.
hTrials 1–5 Free Recall Correct.
iTotal semantic clustering scores on trials 1–5.
jThe number of correct responses standardized to a z-score based on the COGS community control subjects.
doi:10.1371/journal.pone.0088379.t002
Table 3. Significant terms involving paternal age at birth in linear and linear mixed-effects models for endophenotype
performance.
Schizophrenia subjects only Schizophrenia subjects and unaffected siblings combined
Endophenotype Significant term
a (slope
b, P value
c,d, 95% CI) R
2 Significant term
a (slope
b, P value
d,e, 95% CI) R
2
CPT-IP 4-digit Paternal age (slope=0.19, P=0.03, 95% CI=[0.01, 0.36]) 0.11 Paternal age (slope=0.20, P=0.02, 95% CI=[0.03, 0.37]) 0.41
Verbal memory Paternal age by Multiplex status (Simplex slope=20.07,
95% CI=[20.42, 0.29]; Multiplex slope=21.0, 95% CI=
[21.9, 20.15]; P for difference in slopes=0.03)
0.13 Paternal age by Multiplex status (Simplex slope=20.05, 95%
CI=[20.34, 0.25]; Multiplex slope=20.89, 95% CI=[21.5, 2
0.32]; P for difference in slopes=0.005)
0.30
Paternal age by Gender (Male slope=20.05, 95% CI=[20.34,
0.25]; Female slope=20.43, 95% CI=[20.83, 20.03]; P for
difference in slopes=0.049)
Abbreviations: CI, confidence interval; CPT-IP, Continuous Performance Test, Identical Pairs version.
aOnly terms involving paternal age at subject birth with an associated P value ,0.05 are reported, and only endophenotypes with such terms are reported.
bSlope and confidence intervals are in units of a 10-year increase in paternal age at birth. A positive slope indicates that subjects with older fathers perform better on the
endophenotype.
cP values are based on linear models with effects for paternal age, paternal age–by-gender, and paternal age–by–multiplex status, with subject age, test site, subject
gender, and parental education as covariates.
dAfter adjusting for multiple comparisons accounting for the 16 endophenotypes, none of the results are significant at an overall Type I error level of 5%.
eP values are based on linear mixed-effects models with effects for paternal age, paternal age–by-gender, and paternal age–by–multiplex status, with group (proband
versus sibling), subject age, test site, subject gender, parental education, and all second-order interactions involving group as covariates. Family membership served as a
random effect to account for the relatedness of observations among family members.
doi:10.1371/journal.pone.0088379.t003
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symptoms (as measured by the SANS) nor age of onset between
the probands with younger fathers and the probands with older
fathers. This finding contrasts with recent research demonstrating
a relationship between advanced paternal age at birth and positive
symptoms as measured by the PANSS [20]. It is possible that the
differences between our findings and the findings in the study by
Rosenfield and colleagues [20] could be explained by differences
in our study design; for example, our study included probands who
were on antipsychotic medications (their symptoms may have
therefore been less severe), whereas the study by Rosenfield and
colleagues only included unmedicated subjects. Furthermore, our
study used a family-based design rather than a case-control design,
and this difference in recruitment methodology may have
contributed to our nonsignificant findings.
Our study has some limitations. First, as mentioned in our
comparison with the study by Rosenfield and colleagues, the
severity of schizophrenia symptoms might be more evident when
subjects are not on antipsychotics, and thus our inclusion of such
subjects may make our results difficult to compare to studies that
excluded subjects on antipsychotics. Second, subjects who were
missing data for paternal age at birth tended to display poorer
clinical outcomes than subjects with paternal age data available. If
these subjects tended to have higher (or lower) paternal age at
birth than the subjects with paternal age data available, this could
potentially bias our results. And third, our study had a relatively
high number of subjects with missing endophenotype data, and if
these missing values were not missing at random, there is a
potential for bias.
In summary, findings from our study do not suggest that
advanced paternal age has a substantial effect on the endophe-
notypic deficits in schizophrenia probands or their unaffected
siblings, nor on the severity of clinical symptoms or the age of
onset of schizophrenia. The strength of this study is that its large,
clinically well-characterized family-based sample enabled a
thorough investigation of these associations. Another strength of
our study is that we collected endophenotypic data from
unaffected siblings in families with schizophrenia (not unrelated
controls), which allowed us to make direct comparisons between
affected and unaffected individuals who had the same fathers.
Although the mechanisms by which advanced paternal age
increases the risk of developing schizophrenia remain unknown,
they do not appear to play a substantial role in the presence of
endophenotypic deficits in schizophrenia. Additional studies are
necessary to increase our understanding of the ways in which
factors associated with advanced paternal age may adversely affect
the developing brain.
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Table S1 Terms involving paternal age at birth in linear and
linear mixed-effects models for endophenotype performance.
Abbreviations: CI, confidence interval; CPT-IP, Continuous
Performance Test, Identical Pairs version; LNS, Letter-Number
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a Only terms
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b Slope and
confidence intervals are in units of a 10-year increase in paternal
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c P values are based
on linear models with effects for paternal age, paternal age–by-
gender, and paternal age–by–multiplex status, with subject age,
test site, subject gender, and parental education as covariates.
d
After adjusting for multiple comparisons accounting for the 16
endophenotypes, none of the results are significant at an overall
Type I error level of 5%.
e P values are based on linear mixed-
effects models with effects for paternal age, paternal age–by-
gender, and paternal age–by–multiplex status, with group
(proband versus sibling), subject age, test site, subject gender,
parental education, and all second-order interactions involving
group as covariates. Family membership served as a random effect
to account for the relatedness of observations among family
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